Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
10.84
-0.27 (-2.43%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $924.8 million as of October 23, 2026. It is the 10,507th most valuable company in the world and the 2,285th biggest in the United States. Its market cap has increased by 60.15% in one year.
Market Cap
924.80M
Enterprise Value
341.68M
1-Year Change
60.15%
Global Rank
Country Rank
#2,285 United States
Category
ChartMarket Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $924.80M, an increase of 9.40%. That is a compound annual growth rate of 1.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 924.80M | -9.43% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MannKind | 999.99M |
| Cullinan Therapeutics | 972.08M |
| MeiraGTx Holdings | 955.15M |
| Jade Biosciences | 942.51M |
| ArriVent BioPharma | 941.28M |
| Rigel Pharmaceuticals | 925.68M |
| Alto Neuroscience | 921.60M |
| SpyGlass Pharma | 921.32M |